inovio pharmaceuticals inc
(INO:NYSE Amex)
As of 8:04 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).
Financial Statements for inovio pharmaceuticals inc (INO)
Year over year, Inovio Pharmaceuticals, Inc. has seen revenues fall from $9.8M USD to $4.1M USD. This along with an increase in the cost of goods sold expense has led to a reduction in the bottom line from a loss of $15.3M USD to an even larger loss of $19.7M USD.
| Currency in Millions of US Dollars | As of: | Dec 31 2009 | Dec 31 2010 | Dec 31 2011 | Dec 31 2012 | 4 Year Trend |
| Revenues | 9.1 | 6.1 | 9.8 | 4.1 |  | |
| TOTAL REVENUES | 9.1 | 6.1 | 9.8 | 4.1 | | |
| Cost of Goods Sold | 8.8 | 12.6 | 19.6 | 17.5 | | |
| GROSS PROFIT | 0.3 | -6.5 | -9.8 | -13.4 | | |
| Selling General & Admin Expenses, Total | 14.3 | 12.7 | 12.4 | 11.2 | | |
| OTHER OPERATING EXPENSES, TOTAL | 14.3 | 12.7 | 12.4 | 11.2 | | |
| OPERATING INCOME | -14.0 | -19.2 | -22.2 | -24.6 | | |
| Interest and Investment Income | 0.0 | 0.1 | 0.0 | 0.2 | | |
| Other Non-Operating Expenses, Total | -10.5 | 2.4 | 8.7 | 2.0 | | |
| Other Non-Operating Income (Expenses) | -1.3 | 2.4 | 8.7 | 2.0 | | |
| Gain (Loss) on Sale of Investments | -- | -1.0 | -2.4 | 1.6 | | |
| Gain (Loss) on Sale of Assets | -- | -- | 0.6 | 1.2 | | |
| EBT, INCLUDING UNUSUAL ITEMS | -24.5 | -17.6 | -15.3 | -19.7 | | |
| Minority Interest in Earnings | 0.0 | 0.0 | 0.1 | 0.0 | | |
| Earnings from Continuing Operations | -24.5 | -17.6 | -15.3 | -19.7 | | |
| NET INCOME | -24.4 | -17.6 | -15.3 | -19.7 | | |
| NET INCOME TO COMMON INCLUDING EXTRA ITEMS | -24.4 | -17.6 | -15.3 | -19.7 | | |
| NET INCOME TO COMMON EXCLUDING EXTRA ITEMS | -24.4 | -17.6 | -15.3 | -19.7 | | |
| Recently Viewed | |||
| INO:US | $0.71 USD | +0.0295 |  |
| Company | Last | Change |
| Agenus Inc | $4.01 USD | -0.13 |
| Biosante Pharmaceuticals Inc | $1.15 USD | 0.00 |
| Progenics Pharmaceuticals Inc | $4.02 USD | -0.15 |
| Sarepta Therapeutics Inc | $36.65 USD | -0.48 |
| Vical Inc | $3.63 USD | +0.02 |
| View Industry Companies | ||
Industry Analysis
INO
Industry Average
| Valuation | INO | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 27.3x |
|
| Price/Book | 3.1x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 24.1x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Wheat Ridge, CO | TruGreen CompaniesPosted: May 21
